Active Ingredient History
A dendritic cell (DC) is an antigen-presenting cell of the mammalian immune system. A DC's main function is to process antigen material and present it on the cell surface to the T cells of the immune system. They act as messengers between the innate and adaptive immune systems. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Astrocytoma (Phase 1)
Brain Neoplasms (Phase 1)
Breast Neoplasms (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Pancreatic Ductal (Phase 1/Phase 2)
Carcinoma, Renal Cell (Phase 2)
Catheters (Phase 1/Phase 2)
Cells (Phase 1/Phase 2)
Colorectal Neoplasms (Phase 2)
Diabetes Mellitus, Type 1 (Phase 1)
Drug Therapy (Phase 1/Phase 2)
Endometrial Neoplasms (Phase 2)
Ependymoma (Phase 1)
Glioblastoma (Phase 2)
Glioma (Phase 1/Phase 2)
Hamartoma (Phase 1/Phase 2)
Head and Neck Neoplasms (Phase 1)
Hepatectomy (Phase 2)
HIV Infections (Phase 1/Phase 2)
Immune Checkpoint Inhibitors (Phase 1/Phase 2)
Immunotherapy (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1/Phase 2)
Liver Neoplasms (Phase 2)
Lung Neoplasms (Phase 1/Phase 2)
Lymphoma (Phase 1/Phase 2)
Lymphoma, B-Cell, Marginal Zone (Phase 1/Phase 2)
Lymphoma, Follicular (Phase 1/Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 1/Phase 2)
Lymphoma, Large-Cell, Immunoblastic (Phase 1/Phase 2)
Lymphoma, Mantle-Cell (Phase 1/Phase 2)
Lymphoma, Non-Hodgkin (Phase 1/Phase 2)
Medulloblastoma (Phase 1)
Melanoma (Phase 3)
Mesothelioma (Phase 1/Phase 2)
Multiple Myeloma (Phase 2)
Nasopharyngeal Carcinoma (Phase 2)
Neoplasms (Phase 2)
Osteosarcoma (Phase 1)
Ovarian Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 1/Phase 2)
Peritoneal Neoplasms (Phase 1/Phase 2)
Prostatic Neoplasms (Phase 1)
Radiofrequency Ablation (Phase 2)
Sarcoma (Phase 2)
Stomach Neoplasms (Phase 1/Phase 2)
Urinary Bladder Neoplasms (Phase 1/Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue